Publicaciones en las que colabora con Rafael Martínez Monge (8)

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

2008

  1. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  2. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: A phase II study

    Breast Cancer Research and Treatment, Vol. 76, Núm. 1, pp. 47-56

  3. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: A phase II study

    Clinical Colorectal Cancer, Vol. 2, Núm. 2, pp. 104-110

2001

  1. Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma: A multicenter phase II study

    Cancer, Vol. 92, Núm. 9, pp. 2435-2443

2000

  1. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma: A phase II study

    Cancer, Vol. 89, Núm. 12, pp. 2622-2629